All News about Celldex Therapeutics, Inc. - Common Stock

Demystifying Celldex Therapeutics: Insights From 6 Analyst Reviews
January 29, 2025
Via Benzinga


What Analysts Are Saying About Celldex Therapeutics Stock
December 20, 2024
Via Benzinga

Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis
December 19, 2024
Via GlobeNewswire


Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
November 20, 2024
Via Benzinga

Celldex Therapeutics to Present at Upcoming Investor Conferences
November 11, 2024
Via GlobeNewswire

Analyst Expectations For Celldex Therapeutics's Future
October 28, 2024
Via Benzinga



A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics
September 25, 2024
Via Benzinga

This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
September 27, 2024
Via Benzinga



The Analyst Verdict: Celldex Therapeutics In The Eyes Of 7 Experts
September 09, 2024
Via Benzinga

7 Analysts Have This To Say About Celldex Therapeutics
August 12, 2024
Via Benzinga

Analyst Expectations For Celldex Therapeutics's Future
July 16, 2024
Via Benzinga

Analyst Expectations For Celldex Therapeutics's Future
June 03, 2024
Via Benzinga

Celldex Therapeutics to Present at Upcoming Investor Conferences
September 12, 2024
Via GlobeNewswire










Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.